Participate in Surveys and WIN POINTS!

Survey on Pink eye

Pink eye, also known as conjunctivitis, is a common and highly contagious eye infection characterized by inflammation of the conjunctiva – the thin, clear tissue that lines the inside of the eyelid and covers the whites of the eyes. This condition earns its name due to the telltale symptom it presents: reddish or pink discoloration in one or both eyes. Pink eye can be caused by several factors including bacterial or viral infections, allergies, irritants like smoke or chemicals, and even certain sexually transmitted diseases. Regardless of its origins, pink eye typically manifests with uncomfortable symptoms such as itching, burning sensations, excessive tearing, or discharge which may lead to crusting around the eyes. While proper hygiene practices such as handwashing and avoiding touching your face can help prevent this ailment from spreading further among individuals in close proximity – particularly in places like schools or offices where transmission is swift – timely medical intervention remains crucial to alleviate discomfort and prevent prolonged recuperation periods associated with this common ocular affliction.


To take this Survey and to participate in more such Surveys

Recommended Surveys

Survey on childhood asthma


Survey on H3N2 flu


Survey on COVID-related depression


Survey on hair fall


Survey on use of probiotics


Survey on treating Hereditary angioedema


Survey on use of clobazam


Survey on Growth hormone deficiency


CI-AKI awareness survey


Survey on Childhood trauma


Booster vaccine survey


Survey on Viral Hepatitis


Survey on fecal microbiota transplantation


Survey on use of Valproic acid


Diabetes survey


Survey on NAFLD


Survey on treating infections caused by multi-drug resistant organisms


Survey on Telemedicine Usage Among Healthcare Professionals


Survey on the use of neuroleptics


Survey on Effects peripheral neuropathy on Diabetes



Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Whats more on Hidoc Dr.

News
Quizzes
Surveys
Events

Daily news to keep you up to date

Participate and win exciting prizes

Participate and win cash vouchers

Get updates on the latest events happening around the world



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot